Eggert J H, Dumbach J, Steinhäuser E W
Hautarzt. 1986 Aug;37(8):444-9.
Based on a retrospective follow-up study of patients with lower-lip carcinoma from 1968 to 1980, the incidence of metastases of such lesions was broken down according to tumor classification, and the survival rates for these patients were computed. In the total group of 89 patients with primary surgical treatment of the tumor and lymph nodes, 17 (19.1%) were found to have metastases. Among these tumors, 5 were classified as T1, 10 as T2, and 2 as T3. Analysis of the survival rate yielded the following results. To date, there has been no recurrence in any of the patients who underwent suprahyoid lymph-node removal with no histological evidence of lymph-node metastases. Of the 17 patients in whom histological lymph-node metastases were identified in the submandibular region following primary suprahyoid neck dissection, 64.7% showed no evidence of disease for 5 years on average, and all are still alive. In contrast, 90% of the patients died in whom the primary tumor was just treated locally and who did not undergo radical removal of the suprahyoid lymph-node until secondary metastases had occurred. In the light of our experience, suprahyoid lymph-node removal appears to be indicated as part of the primary treatment of lower-lip carcinoma, independent of the prevailing tumor stage. This may not apply to tumors that are clearly less than 1 cm in size.
基于对1968年至1980年下唇癌患者的回顾性随访研究,根据肿瘤分类对这类病变的转移发生率进行了分析,并计算了这些患者的生存率。在89例接受肿瘤及淋巴结初次手术治疗的患者中,有17例(19.1%)发生了转移。在这些肿瘤中,5例为T1期,10例为T2期,2例为T3期。生存率分析得出以下结果。迄今为止,在接受舌骨上淋巴结清扫且无组织学证据表明有淋巴结转移的患者中,无一例复发。在初次舌骨上颈部清扫术后,在颌下区发现有组织学证据表明存在淋巴结转移的17例患者中,平均有64.7%的患者在5年内无疾病证据,且全部存活。相比之下,仅对原发肿瘤进行局部治疗且直到发生继发性转移才进行舌骨上淋巴结根治性切除的患者,90%死亡。根据我们的经验,舌骨上淋巴结清扫似乎应作为下唇癌初次治疗的一部分,与当前肿瘤分期无关。但对于明显小于1厘米的肿瘤可能不适用。